Upgrade

Psyence Biomedical Ltd.

PBM

Last
$4.97
Day
-2.9%
1y
+15.3%
5y
-99.6%
52w
-69.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
5.28
EMA 50
4.85
EMA 200
7.52
20d high
-28.7%
5y high
-99.8%
5y range
0th
Website · 12 employees · Canada

Positions held

Your positions

PBM isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
2
Hold
watch
Signal
Neutral
Target
$5.28
Stop
$4.46
Stop distance
10.3%
Target vs last
+6.2%

Fundamentals

Market cap—Enterprise value$12.08MTrailing P/E—Forward P/E—
PEG—Price / book0.69Beta1.69Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-58.6%ROA-31.3%Debt / equity—
Current ratio14.62Free cash flow-$4.96MAnalyst recommendationnoneMean target—
52w high$163.2852w low$1.92

Quarterly

2025-Q3
Revenue$0.0M
Op margin—
Net income-$0.8M
Gross margin—
Gross profit—
Operating income-$1.5M

Yearly (6y)

20262025202420232022
Revenue$0.0M$0.0M$0.0M$0.0M—
Op margin—————
Net income-$6.9M$1.0M-$51.2M-$3.2M—
Gross margin—————
Gross profit—————
Operating income-$5.9M-$3.7M-$43.4M-$3.2M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

No headlines.

PBM · daily-16.1% over 13 sessions
Close EMA21 EMA50 EMA200
4.725.366.016.667.302026-092026-092026-092026-092026-102026-102026-10